首页 | 本学科首页   官方微博 | 高级检索  
     


Procedural elements involved in maintaining bioanalytical data integrity for good laboratory practices studies and regulated clinical studies
Authors:Christopher A. James  Howard M. Hill
Affiliation:2Pharmaceutical Development, Huntingdon Life Sciences, Huntingdon, PE28 4HS Cambridge, UK ;1Pharmacokinetics and Drug Metabolism, Amgen Inc, One Amgen Center Drive, Mail Stop 30e-2-B, 91320-1799 Thousand Oaks, CA
Abstract:This article describes procedural elements involved in ensuring the integrity of bioanalytical data. These elements can be divided into 3 areas. First, there are those ensuring the integrity of the analyte until analysis, through correct sample collection, handling, shipment, and storage procedures. Incorrect procedures can lead to loss of analyte via instability, addition of analyte through contamination or instability of related metabolites, or changes in the matrix composition that may adversely affect the performance of the analytical method. Second, the integrity of the sample identity needs to be maintained to ensure that the final result reported relates to the individual sample that was taken. Possible sources of error include sample mixup or mislabeling, or errors in data handling. Finally, there is the overall integrity of the documentation that supports the analysis, and any prestudy validation of the method. This includes a wide range of information, from paper and electronic raw data, through standard operating procedures and analytical procedures and facility records, to study plans and final reports. These are critical to allow an auditor or regulatory body to reconstruct the study.
Keywords:Sample integrity   audit trails   bioanalytical methods validation   GLP
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号